• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定去势依赖和独立的驱动基因和途径在去势抵抗性前列腺癌(CRPC)中。

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC).

机构信息

College of Life Sciences, Yantai University, 30th Qingquan Road, 264005, Yantai, Shandong Province, China.

School of Life Sciences, Sun Yat-sen University, 510275, Guangzhou, Guangdong Province, China.

出版信息

BMC Urol. 2022 Oct 18;22(1):162. doi: 10.1186/s12894-022-01113-5.

DOI:10.1186/s12894-022-01113-5
PMID:36258196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9580185/
Abstract

BACKGROUND

Prostate cancer (PCa) is one of the most diagnosed cancers in the world. PCa inevitably progresses to castration-resistant prostate cancer (CRPC) after androgen deprivation therapy treatment, and castration-resistant state means a shorter survival time than other causes. Here we aimed to define castration-dependent and -independent diver genes and molecular pathways in CRPC which are responsible for such lethal metastatic events.

METHODS

By employing digital gene expression (DGE) profiling, the alterations of the epididymal gene expression profile in the mature and bilateral castrated rat were explored. Then we detect and characterize the castration-dependent and -independent genes and pathways with two data set of CPRC-associated gene expression profiles publicly available on the NCBI.

RESULTS

We identified 1,632 up-regulated and 816 down-regulated genes in rat's epididymis after bilateral castration. Differential expression analysis of CRPC samples compared with the primary PCa samples was also done. In contrast to castration, we identified 97 up-regulated genes and 128 down-regulated genes that changed in both GEO dataset and DGE profile, and 120 up-regulated genes and 136 down-regulated genes changed only in CRPC, considered as CRPC-specific genes independent of castration. CRPC-specific DEGs were mainly enriched in cell proliferation, while CRPC-castration genes were associated with prostate gland development. NUSAP1 and NCAPG were identified as key genes, which might be promising biomarkers of the diagnosis and prognosis of CRPC.

CONCLUSION

Our study will provide insights into gene regulation of CRPC dependent or independent of castration and will improve understandings of CRPC development and progression.

摘要

背景

前列腺癌(PCa)是世界上最常见的癌症之一。在雄激素剥夺治疗后,PCa 不可避免地进展为去势抵抗性前列腺癌(CRPC),而去势抵抗状态意味着比其他原因存活时间更短。在这里,我们旨在定义 CRPC 中依赖和不依赖去势的 diver 基因和分子途径,这些基因和分子途径负责导致这种致命的转移事件。

方法

通过采用数字基因表达(DGE)谱分析,探索成熟和双侧去势大鼠附睾基因表达谱的变化。然后,我们利用两个公开的 NCBI 上的与 CRPC 相关的基因表达谱数据集,检测和表征依赖去势和不依赖去势的基因和途径。

结果

我们在大鼠附睾中鉴定出 1632 个上调和 816 个下调基因。还对 CRPC 样本与原发性 PCa 样本进行了差异表达分析。与去势相比,我们在 GEO 数据集和 DGE 图谱中鉴定出 97 个上调基因和 128 个下调基因发生变化,而在 CRPC 中仅鉴定出 120 个上调基因和 136 个下调基因发生变化,这些基因被认为是不依赖于去势的 CRPC 特异性基因。CRPC 特异性差异表达基因主要富集在细胞增殖中,而 CRPC-去势基因与前列腺发育有关。NUSAP1 和 NCAPG 被鉴定为关键基因,它们可能是 CRPC 诊断和预后的有前途的生物标志物。

结论

我们的研究将深入了解 CRPC 依赖或不依赖去势的基因调控,并将提高对 CRPC 发展和进展的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/378c46fb8973/12894_2022_1113_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/6230307914d5/12894_2022_1113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/8f0648b6404d/12894_2022_1113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/e528af78524b/12894_2022_1113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/4dc3bafa0fe2/12894_2022_1113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/ecb7087060ea/12894_2022_1113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/378c46fb8973/12894_2022_1113_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/6230307914d5/12894_2022_1113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/8f0648b6404d/12894_2022_1113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/e528af78524b/12894_2022_1113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/4dc3bafa0fe2/12894_2022_1113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/ecb7087060ea/12894_2022_1113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4209/9580185/378c46fb8973/12894_2022_1113_Fig6_HTML.jpg

相似文献

1
Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC).鉴定去势依赖和独立的驱动基因和途径在去势抵抗性前列腺癌(CRPC)中。
BMC Urol. 2022 Oct 18;22(1):162. doi: 10.1186/s12894-022-01113-5.
2
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.患者来源的激素敏感型前列腺癌异种移植模型揭示生长因子受体结合蛋白 10 作为雄激素受体抑制基因,驱动去势抵抗性前列腺癌的发展。
Eur Urol. 2018 Jun;73(6):949-960. doi: 10.1016/j.eururo.2018.02.019. Epub 2018 Mar 12.
3
Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.原发性前列腺癌中预先存在的去势抵抗性前列腺癌细胞样细胞促进对激素治疗的抵抗。
Eur Urol. 2022 May;81(5):446-455. doi: 10.1016/j.eururo.2021.12.039. Epub 2022 Jan 17.
4
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer.CDK6 上调,可能成为恩杂鲁胺耐药性去势抵抗性前列腺癌的潜在治疗靶点。
Eur J Med Res. 2022 Jul 2;27(1):105. doi: 10.1186/s40001-022-00730-y.
5
ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.ZRSR2 过表达是去势抵抗性前列腺癌发展中的一个常见且早期事件。
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):775-785. doi: 10.1038/s41391-021-00322-7. Epub 2021 Feb 10.
6
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.接受雄激素剥夺治疗的晚期前列腺癌的下一代测序
Eur Urol. 2014 Jul;66(1):32-9. doi: 10.1016/j.eururo.2013.08.011. Epub 2013 Aug 14.
7
and are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine.和 是前列腺癌进展和多柔比星耐药的去势抵抗性前列腺癌的关键基因。
Front Endocrinol (Lausanne). 2022 Dec 19;13:1106175. doi: 10.3389/fendo.2022.1106175. eCollection 2022.
8
Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.激素敏感性前列腺癌和去势抵抗性前列腺癌中雄激素受体变异体7和泛素结合酶2C的转录水平
Prostate. 2017 Jan;77(1):60-71. doi: 10.1002/pros.23248. Epub 2016 Aug 22.
9
Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.阿比特龙将去势抵抗性前列腺癌的依赖性从肾上腺雄激素转向雄激素受体变体和糖皮质激素受体信号。
Prostate. 2022 Apr;82(5):505-516. doi: 10.1002/pros.24297. Epub 2022 Jan 17.
10
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.MED15 编码中介体复合物的一个亚基,在去势抵抗性前列腺癌中高频过表达。
Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9.

引用本文的文献

1
The role and therapeutic value of NUSAP1 in human cancers.NUSAP1在人类癌症中的作用及治疗价值。
J Transl Med. 2025 Jul 2;23(1):725. doi: 10.1186/s12967-025-06746-2.
2
Important role and underlying mechanism of non‑SMC condensin I complex subunit G in tumours (Review).非 SMC 凝聚素 I 复合物亚基 G 在肿瘤中的重要作用和潜在机制(综述)。
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8736. Epub 2024 Apr 19.

本文引用的文献

1
Metastatic Prostate Cancer: Treatment Options.转移性前列腺癌:治疗选择
Oncology. 2022;100(1):48-59. doi: 10.1159/000519861. Epub 2021 Nov 15.
2
An up-to-date evaluation of abiraterone for the treatment of prostate cancer.阿比特龙治疗前列腺癌的最新评价。
Expert Opin Pharmacother. 2021 Jul;22(10):1227-1234. doi: 10.1080/14656566.2021.1915287. Epub 2021 Apr 27.
3
Hormonal Therapy for Prostate Cancer.前列腺癌的激素治疗。
Endocr Rev. 2021 May 25;42(3):354-373. doi: 10.1210/endrev/bnab002.
4
Genome-wide prediction and comparative transcriptomic analysis reveals the G protein-coupled receptors involved in gonadal development of Apostichopus japonicus.全基因组预测和比较转录组分析揭示了参与日本刺参性腺发育的 G 蛋白偶联受体。
Genomics. 2021 Jan;113(1 Pt 2):967-978. doi: 10.1016/j.ygeno.2020.10.030. Epub 2020 Nov 2.
5
Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study.在社区环境下对局限性前列腺癌进行主动监测的长期结果:一项前瞻性非干预性研究的结果。
World J Urol. 2021 Jul;39(7):2515-2523. doi: 10.1007/s00345-020-03471-x. Epub 2020 Sep 30.
6
Network Building with the Cytoscape BioGateway App Explained in Five Use Cases.用五个用例解释 Cytoscape BioGateway App 的网络构建。
Curr Protoc Bioinformatics. 2020 Dec;72(1):e106. doi: 10.1002/cpbi.106.
7
NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling.NCAPG通过PI3K/AKT信号通路促进肝细胞癌的增殖。
Onco Targets Ther. 2019 Oct 16;12:8537-8552. doi: 10.2147/OTT.S217916. eCollection 2019.
8
Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.NUSAP1 的下调通过抑制胃癌中的 mTORC1 信号通路抑制细胞增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Jan;38(1):28-37. doi: 10.1002/cbf.3444. Epub 2019 Nov 11.
9
Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment.去势抵抗性前列腺癌:机制、靶点与治疗。
Adv Exp Med Biol. 2018;1096:117-133. doi: 10.1007/978-3-319-99286-0_7.
10
Network analysis of microRNAs, transcription factors, and target genes involved in axon regeneration.涉及轴突再生的 microRNAs、转录因子和靶基因的网络分析。
J Zhejiang Univ Sci B. 2018;19(4):293-304. doi: 10.1631/jzus.B1700179.